Stocktoria
Outlook Therapeutics, Inc. OTLK
Outlook Therapeutics, Inc. statistics & valuation
Market cap$273.9M
Net margin-4416.2%
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports.
Profitability & efficiency
Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | 4.0% | — | — | — | — | — | — | — | — | — |
| Operating margin | -4744.3% | — | — | — | — | — | -445.6% | -960.1% | — | -941.4% |
| Net margin | -4416.2% | — | — | — | — | — | -423.8% | -974.6% | — | -1019.3% |
| FCF margin | — | — | — | — | — | — | -401.8% | -1160.2% | — | -414.5% |
| Return on assets | -335.9% | -261.5% | -182.6% | -231.5% | -233.1% | -178.6% | -201.5% | -135.0% | — | -187.4% |
| Return on equity | 193.9% | 103.1% | 408.5% | -756.0% | -1153.9% | -1246.8% | 214.0% | 117.8% | — | 115.4% |
| Debt / equity | — | — | — | — | — | — | -66.74× | -0.01× | -0.01× | -0.01× |
| Current ratio | 0.38 | 0.64 | 0.66 | 1.39 | 3.19 | 1.13 | 0.67 | 0.10 | 0.49 | 0.14 |
Computed from company filings · US · as of 2025-09-30. Facts plus Stocktoria's own computed scores — not investment advice.